Huntington Disease Clinical Trial
Official title:
Immediate Effects of Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's Disease
Individuals with Dementia with Lewy Bodies (DLB) and Huntington's disease (HD) experience balance and walking problems that lead to falls. Treadmill walking has demonstrated improvements in balance and walking and fall risk in individuals with Parkinson's disease (PD), suggesting that it may be beneficial for individuals with DLB and HD. In PD subjects, changes in gait parameters have been noted after only one treadmill training session. The investigators propose a pilot study to investigate the safety, feasibility, and utility to improve mobility and fall risk of a single session of treadmill walking in individuals with DLB and HD.
Several studies using HD animal models have shown that HD mice housed in enriched
environments or in cages with running wheels that stimulated physical activity demonstrated
a delayed onset and/or slowed decline in motor function compared to mice in non-enriched
environments (van Dellen et al. 2000, 2008; Spires et al., 2004). Evidence suggests that
aerobic exercise may have neuroprotective effects and helps the elderly and individuals with
neurodegenerative diseases to maintain better cognitive and motor function than those who
are inactive. More specifically, there is strong evidence from animal and human trials in
neurological populations (i.e., Parkinson's Disease, spinal cord injury, and stroke) that
treadmill training can improve walking and motor function. Immediate effects of a
single-session of treadmill walking in the Parkinson's Disease population were improved
over-ground gait measures (i.e., gait speed, stride length, double support percent, stride
variability) and longer term treadmill training studies demonstrated additional improvements
in Unified Parkinson Disease Rating Scale scores, fall risk, and health-related quality of
life (Herman et al., 2008). This study builds upon foundational knowledge gained in animals
and other neurologic populations to determine the feasibility, safety and possible immediate
benefit of treadmill walking in individuals with HD.
The primary purpose of this pilot study is to investigate the the safety, feasibility and
utility of a single 20-minute session of treadmill walking to improve gait parameters in
ambulatory individuals with DLB and HD. Secondarily we will explore the effects of treadmill
walking on mobility, fall risk, and motor coordination. Based on previous studies utilizing
a single-session of treadmill training in the PD population, we hypothesize that treadmill
walking will improve overground spatiotemporal gait parameters (gait speed, stride length,
double support percent, and stride-to-stride variations in gait) in individuals with DLB and
HD (Pohl et al., 2003; Frenkel-Toledo et al., 2005; Bello et al., 2008).
;
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Not yet recruiting |
NCT04429230 -
Non-invasive Brain Stimulation in Huntington's Disease
|
N/A | |
Recruiting |
NCT05032196 -
Study of WVE-003 in Patients With Huntington's Disease
|
Phase 1/Phase 2 | |
Recruiting |
NCT03599076 -
Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease Huntington's Disease
|
||
Terminated |
NCT04617860 -
Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT05748288 -
Development of the Virtual Unified Huntington's Disease Rating Scale
|
||
Not yet recruiting |
NCT05360082 -
Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
|
||
Not yet recruiting |
NCT04370470 -
Development of Assessments for Later Stage HD
|
||
Recruiting |
NCT01834053 -
Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.
|
Phase 1/Phase 2 | |
Completed |
NCT01458470 -
A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease
|
Phase 2 | |
Completed |
NCT01357681 -
Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)
|
Phase 2 | |
Completed |
NCT00980694 -
Bioavailability of Ubiquinol in Huntington Disease
|
Phase 1 | |
Completed |
NCT00146211 -
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
|
Phase 3 | |
Recruiting |
NCT01412125 -
Study of Biomarkers That Predict the Evolution of Huntington's Disease
|
N/A | |
Completed |
NCT00075140 -
Family Health After Predictive Huntington Disease (HD) Testing
|
Phase 3 | |
Recruiting |
NCT04818060 -
Preparing for Prevention of Huntington's Disease (PREVENT-HD)
|
||
Active, not recruiting |
NCT04698551 -
NIPD on cffDNA for Triplet Repeat Diseases
|
||
Not yet recruiting |
NCT04301726 -
Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated With HD
|
Phase 1 | |
Completed |
NCT03421327 -
Genetic Risk: Whether, When, and How to Tell Adolescents
|
||
Recruiting |
NCT03296176 -
Metabolomic Study in Huntington's Disease (METABO-HD)
|
N/A |